Garuda Therapeutics raised $50 million in a Series A-1 funding round led by OrbiMed, Northpond Ventures, and Cormorant Asset Management to advance off-the-shelf blood stem cell therapies.
Amount Raised
$50 Million
Round Type
Series A
CambridgeBiotechnologyHealth CareScience And EngineeringInvestors
Description
Garuda Therapeutics has successfully completed a $50 million Series A-1 financing round to support the advancement of their HSC therapies. This funding will help scale manufacturing and advance their technology towards clinical development.
Quick answer
Garuda Therapeutics raised $50 Million in a Series A round, dated March 5, 2025. Investors: Cormorant Asset Management, Northpond Ventures, Kyowa Kirin Co., Ltd. and Orbimed. Garuda Therapeutics is based in Cambridge, Massachusetts, United States.
- How much did Garuda Therapeutics raise?
- Garuda Therapeutics raised $50 Million in a Series A round on March 5, 2025.
- Who invested in Garuda Therapeutics?
- Cormorant Asset Management, Northpond Ventures, Kyowa Kirin Co., Ltd. and Orbimed are named as investors in this round.
- What does Garuda Therapeutics do?
- Garuda Therapeutics seeks to eliminate the need for stem cell donors for blood stem cell transplants.
- Where is Garuda Therapeutics based and how big is it?
- Garuda Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 55 employees.
- Who are the decision-makers at Garuda Therapeutics?
- Fundz holds 1 contact at Garuda Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who to call at Garuda Therapeutics, and when
A new round usually means Garuda Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Garuda Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Garuda Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Garuda Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Garuda Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGaruda Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.